Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Nov 12;18(2):105–125. doi: 10.1016/0166-3542(92)90032-Z

A view from the common cold unit

DAJ Tyrrell 1
PMCID: PMC7133934  PMID: 1329647

Abstract

I have been asked to stand back and describe in broad terms the view I have had of common colds — probably the most frequent of acute human diseases and a long-lasting scientific problem — and in particular our recent work on antivirals. I should be able to do this for two reasons. Like everyone else I have suffered from colds, but in addition I have been studying the problem from the virological and clinical point of view for over 35 years — for the last 31 at the Common Cold Unit, Salisbury. As a result I may have problems with perspective — it is not possible to give a personal view and at the same time to describe something from every possible angle, and quite impossible to be comprehensive, but I have done my best and readers will make their own judgements and corrections.

Keywords: Common cold, Rhinovirus, Clinical trial

References

  1. Ahmad A.L.M., Tyrrell D.A.J. Synergism between anti-rhinovirus antivirals: various human interferons and a number of synthetic compounds. Antivir. Res. 1986;6:241–252. doi: 10.1016/0166-3542(86)90005-7. [DOI] [PubMed] [Google Scholar]
  2. Al-Nakib W., Higgins P.G., Barrow G.I., Tyrrell D.A.J., Andries K., Vanden Bussche G., Taylor N., Janssen P.A.J. Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837) Antimicrob. Agents Chemother. 1989;33:522–525. doi: 10.1128/aac.33.4.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Al-Nakib W., Higgins P.G., Barrow G.I., Tyrrell D.A.J., Lenox-Smith I., Ishitsuka H. Intranasal chalcone Ro 09-0410 as prophylaxis against rhinovirus infection in volunteers. J. Antimicrob. Chemother. 1987;20:887–892. doi: 10.1093/jac/20.6.887. [DOI] [PubMed] [Google Scholar]
  4. Al-Nakib W., Higgins P.G., Willman J.S., Tyrrell D.A.J., Swallow D.L., Hurst B.C., Rushton A. Prevention and treatment of experimental influenza A virus infection in volunteers with a new antiviral ICI 130,685. J. Antimicrob. Chemother. 1986;18:119–129. doi: 10.1093/jac/18.1.119. [DOI] [PubMed] [Google Scholar]
  5. Al-Nakib W., Willman J., Higgins P.G., Tyrrell D.A.J., Shepherd W.M., Freestone D.S. Failure of intranasally administered 4′-6-dichlorflavan to protect against rhinovirus infection in man. Arch. Virol. 1987;92:255–260. doi: 10.1007/BF01317482. [DOI] [PubMed] [Google Scholar]
  6. Andrewes C.H. The natural history of the common colds. Lancet. 1949;1:71. doi: 10.1016/s0140-6736(49)90398-0. [DOI] [PubMed] [Google Scholar]
  7. Andrewes C.H. The common cold. Sci. Am. 1951;184:39–45. [Google Scholar]
  8. Andrewes C.H., Chaproniere D.M., Gompels A.E.H., Pereira H.G., Roden A.T. Propagation of common cold virus in tissue culture. Lancet. 1953;2:546. doi: 10.1016/s0140-6736(53)90279-7. [DOI] [PubMed] [Google Scholar]
  9. Andries K., Dewindt B., De Brabander M., Stokbroekx R., Janssen P.A.J. In vitro study of R61837, a new antirhinovirus compound. Arch. Virol. 1988;101:155–167. doi: 10.1007/BF01310997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Appleyard G., Russell S.M., Clarke B.E., Spellers S.A., Trowbridge M., Vadolas J. Neutralizing epitopes of human rhinovirus type 2. J. Gen. Virol. 1990;71:1275–1282. doi: 10.1099/0022-1317-71-6-1275. [DOI] [PubMed] [Google Scholar]
  11. Barclay W.S., Al-Nakib W., Higgins P.G., Tyrrell D.A.J. The time course of the humoral immune response to rhinovirus infection. Epidem. Inf. 1989;103:656–669. doi: 10.1017/s095026880003106x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Barrow G.I., Higgins P.G., Al-Nakib W., Smith A.P., Wenham R.B.M., Tyrrell D.A.J. The effect of intranasal nedocromil sodium on viral upper respiratory infections in human volunteers. Clin. Exp. Allergy. 1990;20:45–51. doi: 10.1111/j.1365-2222.1990.tb02774.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Barrow G.I., Higgins P.G., Tyrrell D.A.J., Andries K. An appraisal of the efficacy of the antiviral R61837 in rhinovirus infections in human volunteers. Antiviral Chem. Chemother. 1990;1:279–283. [Google Scholar]
  14. Beare A.S. Live viruses for immunization against influenza. Prog. Med. Virol. 1975;20:49–83. [PubMed] [Google Scholar]
  15. Beare A.S., Reed S.E. The study of antiviral compounds in volunteers. In: Oxford J.S., editor. Vol. 2. CRC Press; Cleveland: 1977. pp. 27–55. (Chemoprophylaxis and Virus Infections of the Respiratory Tract). [Google Scholar]
  16. Bende M., Barrow G.I., Heptonstall J., Higgins P., Al-Nakib W., Tyrrell D.A.J., Åkerlund A. Changes in human nasal mucosa during experimental coronavirus common colds. Acta Otolaryngol. 1989;107:262–269. doi: 10.3109/00016488909127507. [DOI] [PubMed] [Google Scholar]
  17. Bruce C.B., Al-Nakib W., Almond J.W., Tyrrell D.A.J. Use of synthetic oligonucleotide probes to detect rhinovirus RNA. Arch. Virol. 1989;105:179–187. doi: 10.1007/BF01311355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Buckland F.E., Bynoe M.L., Tyrrell D.A.J. Experiments on the spread of colds. II. Studies in volunteers with coxsackie virus A21. J. Hyg. (Camb.) 1965;63:327–343. doi: 10.1017/s0022172400045228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Bynoe M.L., Hobson C., Horner J., Kipps A., Schild G.C., Tyrrell D.A.J. Inoculation of human volunteers with a strain of virus isolated from a common cold. Lancet. 1961;1:1194–1196. doi: 10.1016/s0140-6736(61)91941-9. [DOI] [PubMed] [Google Scholar]
  20. Callow K.A., Tyrrell D.A.J., Shaw R., Fitzharris P., Wardlaw A., Kay A.B. Influence of atopy on the clinical manifestations of coronavirus infections in adult volunteers. Clin. Allerg. 1988;18:119–129. doi: 10.1111/j.1365-2222.1988.tb02851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Carey B.S., Barclay W.S., Russell S.M., Tyrrell D.A.J. The specificity of antibodies induced by infection with rhinovirus type 2. J. Med. Virol. 1992 doi: 10.1002/jmv.1890360404. in press. [DOI] [PubMed] [Google Scholar]
  22. Cate T.R., Couch R.B., Johnson K.M. Studies with rhinoviruses in volunteers: production of illness, effect of naturally acquired antibody, and demonstration of a protective effect not associated with antibody. J. Clin. Inv. 1964;43:56–67. doi: 10.1172/JCI104894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Chanock R.M., Parrott R.H., Cook K., Andrews B.E., Bell J.A., Reichelderfer T., Kapikian A.Z., Huebner R.J. Newly recognised myxoviruses from children with respiratory disease. New Eng. J. Med. 1958;258:207–213. doi: 10.1056/NEJM195801302580502. [DOI] [PubMed] [Google Scholar]
  24. Chapman M.S., Minor I., Rossman M.G., Diana G.D., Andries K. Human rhinovirus 14 complexed with antiviral compound. R61837. J. Mol. Biol. 1991;217:455–463. doi: 10.1016/0022-2836(91)90749-v. [DOI] [PubMed] [Google Scholar]
  25. Cohen S., Tyrrell D.A.J., Smith A.P. Psychological stress and susceptibility to the common cold. New Eng. J. Med. 1991;325:606–612. doi: 10.1056/NEJM199108293250903. [DOI] [PubMed] [Google Scholar]
  26. Couch R.B., Douglas R.G., Lindgren K.M., Gerone P.J., Knight V. Airborne transmission of respiratory infection with coxsackie virus type 21. Am. J. Epidemiol. 1970;9:78–86. doi: 10.1093/oxfordjournals.aje.a121115. [DOI] [PubMed] [Google Scholar]
  27. Dearden C., Al-Nakib W., Andries K., Woestenborghs R., Tyrrell D.A.J. Drug resistant rhinoviruses from the nose of experimentally treated volunteers. Arch. Virol. 1989;109:71–81. doi: 10.1007/BF01310519. [DOI] [PubMed] [Google Scholar]
  28. Dick E.C., Hossain S.U., Mink K.A., Meschievitz C.K., Schultz S.B., Raynor W.J., Inhorn S.L. Interruption of transmission of rhinovirus colds among human volunteers using viricidal paper handkerchiefs. J. Infect. Dis. 1986;153:352–356. doi: 10.1093/infdis/153.2.352. [DOI] [PubMed] [Google Scholar]
  29. Dick E.C., Jennings L.C., Mink K.A., Wartgow C.D., Inhorn S.L. Aerosol transmission of rhinovirus colds. J. Infect. Dis. 1987;156:442–448. doi: 10.1093/infdis/156.3.442. [DOI] [PubMed] [Google Scholar]
  30. Dochez A.R., Mills K.C., Kneeland Y. Vol. 28. 1931. Study of the virus of the common cold and its cultivation in tissue medium; pp. 513–516. (Proc. Soc. Exp. Biol. Med.). [Google Scholar]
  31. Dochez A.R., Shibley G.S., Mills K.C. Studies in the common cold. IV. Experimental transmission of the common cold to anthropoid apes and human beings by means of a filtrable agent. J. Exp. Med. 1930;52:701–716. doi: 10.1084/jem.52.5.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Dowling H.F., Jackson G.G., Inouye T. Transmission of the experimental common cold in volunteers. II. The effect of certain host factors upon susceptibility. J. Lab. Clin. Med. 1957;50:516–525. [PubMed] [Google Scholar]
  33. Dowling H.F., Jackson G.G., Spiesman I.G., Inouye T. Transmission of the common cold to volunteers under controlled conditions. III. The effect of chilling of the subjects under susceptibility. Amer. J. Hyg. 1958;66:59–65. doi: 10.1093/oxfordjournals.aje.a119949. [DOI] [PubMed] [Google Scholar]
  34. Farr B.M., Gwaltney J.M., Jr., Hendley J.O., Hayden F.G., Naclerio R.M., McBride T., Doyle W.J., Sorrentino J.V., Riker D.K., Proud D. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J. Infect. Dis. 1990;162:1173–1174. doi: 10.1093/infdis/162.5.1173. [DOI] [PubMed] [Google Scholar]
  35. Farr B.M., Hendley J.O., Kaiser D.L., Gwaltney J.M. Two randomized controlled trials of virucidal nasal tissues in the prevention of natural upper respiratory infections. Antimicrob. Agents Chemother. 1987;31:1183–1187. doi: 10.1093/oxfordjournals.aje.a115059. [DOI] [PubMed] [Google Scholar]
  36. Francis M.J., Hastings G.Z., Sangar D.V., Clark R.P., Syred A., Clarke B.E., Rowlands D.J., Brown F. A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2. J. Gen. Virol. 1987;68:2687–2691. doi: 10.1099/0022-1317-68-10-2687. [DOI] [PubMed] [Google Scholar]
  37. Gaffey M.J., Hayden F.G., Boyd J.C., Gwaltney J.M. Ipratropium bromide treatment of experimental rhinovirus infection. Antimicrob. Agents Chem. 1988;32:1644–1647. doi: 10.1128/aac.32.11.1644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Gama P.R., Horsnell P.R., Hughes C., North C.B., Bruce C.B., Al-Nakib W., Stanaway G. Amplification of rhinovirus-specific nucleic acids from clinical samples using the polymerase chain reaction. J. Med. Virol. 1989;28:73–77. doi: 10.1002/jmv.1890280204. [DOI] [PubMed] [Google Scholar]
  39. Hendley J.O., Gwaltney J.M., Jordan W.S., Jr. Rhinovirus infections in an industrial population. IV. Infections within families during two fall peaks of respiratory illnesses. Am. J. Epidemiol. 1969;89:184–196. doi: 10.1093/oxfordjournals.aje.a120928. [DOI] [PubMed] [Google Scholar]
  40. Hendley J.O., Wenzel R.P., Gwaltney J.M. Transmission of rhinovirus colds by self-inoculation. New. Eng. J. Med. 1973;288:1361. doi: 10.1056/NEJM197306282882601. [DOI] [PubMed] [Google Scholar]
  41. Higgins P., Al-Nakib W., Barrow G.I., Tyrrell D.A.J. Recombinant human interferon-γ as prophylaxis against rhinovirus colds in volunteers. J. Interferon Res. 1988;8:591–596. doi: 10.1089/jir.1988.8.591. [DOI] [PubMed] [Google Scholar]
  42. Higgins P.G., Barrow I.G., Galbraith A.W., Frost H., Tyrrell D.A.J. A note on the failure of CGP 19835 (MTP-PE) to influence the course of influenza A2 infection in human volunteers. Antiviral Res. 1989;12:49–52. doi: 10.1016/0166-3542(89)90067-3. [DOI] [PubMed] [Google Scholar]
  43. Higgins P.G., Barrow G.I., Tyrrell D.A.J., Isaacs D., Gauci C.L. The efficacy of intranasal interferonα-2a in respiratory syncytial virus infection in volunteers. Antiviral Res. 1990;14:3–10. doi: 10.1016/0166-3542(90)90061-B. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Higgins P.G., Barrow G.I., Tyrrell D.A.J., Snell N.J.C., Jones K., Jolley W.B. A study of the efficacy of the immunomodulatory compound 7-thia-8-oxoguanosine in coronavirus 229E infections in human volunteers. Antiviral Chem. Chemother. 1991;2:61–63. [Google Scholar]
  45. Hitchcock G., Tyrrell D.A.J. Some virus isolations from common colds. 2. Virus Interference in tissue culture. Lancet. 1960;1:237–239. doi: 10.1016/s0140-6736(60)90167-7. [DOI] [PubMed] [Google Scholar]
  46. Knight V. The use of volunteers in medical virology. Progr. Med. Virol. 1964;6:1–26. [PubMed] [Google Scholar]
  47. Kruse W. Die Erreger von Husten und Schnupfen. München. Med. Wochenschr. 1914;61:1547. [Google Scholar]
  48. Larson H.E., Reed S.E., Tyrrell D.A.J. Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J. Med. Virol. 1980;5:221–229. doi: 10.1002/jmv.1890050306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Lovelock J.E., Porterfield J.S., Roden A.T., Sommerville T., Andrewes C.H. Further studies on the natural transmission of the common cold. Lancet. 1952;2:657. doi: 10.1016/s0140-6736(52)91502-x. [DOI] [PubMed] [Google Scholar]
  50. Merigan T.C., Hall T.S., Reed S.E., Tyrrell D.A.J. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973;1:563–567. doi: 10.1016/s0140-6736(73)90714-9. [DOI] [PubMed] [Google Scholar]
  51. Mills K.C., Shibley G.S., Dochez A.R. Studies in the common cold. II. A study of certain gram-negative filter-passing anaerobes of the upper respiratory tract. J. Exp. Med. 1928;47:193–206. doi: 10.1084/jem.47.2.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Monto A.S., Schwartz S.A., Albrecht J.K. Ineffectiveness of post exposure prophylaxis with low-dose intranasal alpha-2b-interferon in families. Antimicrob. Agents Chemother. 1989;33:387–390. doi: 10.1128/aac.33.3.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Myint S., Harmsen T., Raabe T., Siddell S.G. Characterisation of a nucleic acid probe for the diagnosis of human coronavirus 229E infections. J. Med. Virol. 1990;31:165–172. doi: 10.1002/jmv.1890310216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Naclerio R.M., Proud D., Lichtenstein L.M., Kagey-Sobotka A., Hendley J.E., Sorrentino J., Gwaltney J.M. Kinins are generated during experimental rhinovirus colds. J. Infect. Dis. 1987;157:133–142. doi: 10.1093/infdis/157.1.133. [DOI] [PubMed] [Google Scholar]
  55. Nicholson K.G., Tyrrell D.A.J., Oxford J.S., Wood J., Schild G.C., Potter C.W., Jennings R., Michaels R.H., Appleyard G. Infectivity and reactongenicity of reassortant cold-adapted influenza A/Korea/82 vaccines obtained from the USA and USSR. Bull. Wld. Hlth. Org. 1987;65:291–301. [PMC free article] [PubMed] [Google Scholar]
  56. Oxford J.S., Schild G.C., Corcoran T., Newman R., Major D., Robertson T., Bootman J., Higgins P., Al-Nakib W., Tyrrell D.A.J. A host-cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers. Arch. Virol. 1990;110:37–46. doi: 10.1007/BF01310701. [DOI] [PubMed] [Google Scholar]
  57. Pelon W., Mogabgab W.J., Phillips I.A., Pierce W.E. Vol. 94. 1957. A cytopathogenic agent isolated from naval recruits with mild respiratory illness; pp. 262–267. (Proc. Soc. Exp. Biol. Med.). [DOI] [PubMed] [Google Scholar]
  58. Price W. Vol. 42. 1956. The isolation of a new virus associated with respiratory clinical disease in humans; pp. 892–896. (Proc. Natl. Acad. Sci. (Wash.)). [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Proud D., Naclerio R.M., Gwaltney J.M., Hendley J.O. Kinins are generated in nasal secretions during natural rhinovirus colds. J. Inf. Dis. 1990;161:120–123. doi: 10.1093/infdis/161.1.120. [DOI] [PubMed] [Google Scholar]
  60. Reed S.E. An investigation of the possible transmission of rhinovirus colds through indirect contact. J. Hyg. Camb. 1975;75:249–258. doi: 10.1017/s0022172400047288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Reichelderfer T.E., Chanock R.M., Craighead J.E., Huebner R.J., Turner H.C., James W. Infections of human volunteers with type 2 haemoadsorption virus. Science. 1958;128:779–780. doi: 10.1126/science.128.3327.779. [DOI] [PubMed] [Google Scholar]
  62. Rossen R.D., Douglas R.G., Cate T.R., Couch R.B., Butler W.T. The sedimentation of rhinovirus neutralizing activity in nasal secretion and serum following the rhinovirus common cold. J. Immunol. 1966;97:532–538. [PubMed] [Google Scholar]
  63. Rossman M.G. The canyon hypothesis. Viral Immunol. 1989;2:143–161. doi: 10.1089/vim.1989.2.143. [DOI] [PubMed] [Google Scholar]
  64. Rossman M.G., Arnold E., Erickson J.W., Frankenberger E.A., Griffith J.P., Hecht H.-J., Johnson J.E., Kramer G., Mink L., Mosser A.G., Rueckert R.R., Sherry B., Vriend G. The structure of a human cold virus (rhinovirus 14) and its functional relationship to other picornaviruses. Nature. 1985;317:145–153. doi: 10.1038/317145a0. [DOI] [PubMed] [Google Scholar]
  65. Royal College of Physicians Report of Research in Healthy Volunteers. Roy. Coll. Phys. London. 1986 [Google Scholar]
  66. Scientific Committee on Common Cold Vaccines Prevention of colds by vaccination against rhinoviruses. Br. Med. J. 1965;1:1344–1349. [PMC free article] [PubMed] [Google Scholar]
  67. Scott G.M., Phillpotts R.J., Wallace J., Secher D.S., Cantell K., Tyrrell D.A.J. Purified interferon as protection against rhinovirus infection. Br. Med. J. 1982;284:1822–1825. doi: 10.1136/bmj.284.6332.1822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Scott G.M., Tyrrell D.A.J. Antiviral effects of interferon in man. In: Finter N.B., Oldham R.K., editors. In vivo and clinical studies. Vol. 4. Elsevier; Amsterdam: 1985. pp. 181–215. (Interferon). [Google Scholar]
  69. Scott G.M., Wallace J., Greiner J., Phillpotts R.J., Gauci C.L., Tyrrell D.A.J. Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet. 1982;ii:186–188. doi: 10.1016/s0140-6736(82)91031-5. [DOI] [PubMed] [Google Scholar]
  70. Smith W., Andrewes C.H., Laidlaw P.P. A virus obtained from influenza patients. Lancet. 1933;2:66–68. [Google Scholar]
  71. Smith T.J., Kremer H.J., Luo M., Vriend G., Arnold E., Kamer G., Rossman M.G., McKinlay M.A., Diana G.D., Otto M.J. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science. 1986;233:1286–1293. doi: 10.1126/science.3018924. [DOI] [PubMed] [Google Scholar]
  72. Smith A.P., Tyrrell D.A.J., Al-Nakib W., Coyle K.B., Donovan C.B., Higgins P.G., Willman J.S. The effects of experimentally-induced respiratory virus infections on performance. Psychol. Med. 1988;18:65–71. doi: 10.1017/s0033291700001896. [DOI] [PubMed] [Google Scholar]
  73. Smith A., Tyrrell D.A.J., Coyle K., Higgins P. Effects of interferon alpha on performance in man: a preliminary report. Psychopharmacology. 1988;96:414–416. doi: 10.1007/BF00216072. [DOI] [PubMed] [Google Scholar]
  74. Staunton D.E., Merluzzi V.J., Rothlein R., Barton R., Martin S.D., Springer T.A. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell. 1989;56:849–853. doi: 10.1016/0092-8674(89)90689-2. [DOI] [PubMed] [Google Scholar]
  75. Sutton R.N.P., Tyrrell D.A.J. Some observations on interferon prepared in tissue cultures. Br. J. Exp. Pathol. 1961;42:99–105. [Google Scholar]
  76. Thomson D., Thomson R. The Common Cold. Ann. Pickett-Thomson. Res. Lab. 1932;8:1–738. [Google Scholar]
  77. Togo Y., Schwartz A.B., Tominaga S., Hornick R.B. Cyclooctylamine in the prevention of human influenza. J. Am. Med. Ass. 1972;220:837. [PubMed] [Google Scholar]
  78. Tomassini J.E., Colonno R.J. Isolation of a receptor protein involved in attachment of human rhinoviruses. J. Virol. 1986;58:290–295. doi: 10.1128/jvi.58.2.290-295.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Totman R., Kiff J., Reed S.E., Craig J.W. Predicting experimental colds in volunteers from different measures of recent life stress. J. Psychosom. Res. 1980;24:155–163. doi: 10.1016/0022-3999(80)90037-9. [DOI] [PubMed] [Google Scholar]
  80. Tyrrell D.A.J., Barrow I., Arthur J. Local hyperthermia benefits natural and experimental common colds. Br. Med. J. 1989;298:1280–1283. doi: 10.1136/bmj.298.6683.1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Tyrrell D.A.J., Bynoe M.L., Hitchcock G., Pereira H.G., Andrewes C.H. Some virus isolations from common colds. I. Experiments employing human volunteers. Lancet. 1960;1:235. doi: 10.1016/s0140-6736(60)90166-5. [DOI] [PubMed] [Google Scholar]
  82. Tyrrell D.A.J., Parsons R. Some virus isolations from common colds. 3. Cytopathic effects in tissue cultures. Lancet. 1960;1:239–241. doi: 10.1016/s0140-6736(60)90168-9. [DOI] [PubMed] [Google Scholar]
  83. Wilson R., Alton E., Rutman A., Higgins P., Al-Nakib W., Geddes D.M., Tyrrell D.A.J., Cole P.J. Upper respiratory tract viral infection and mucociliary clearance. Eur. J. Resp. Dis. 1987;70:272–279. [PubMed] [Google Scholar]

Articles from Antiviral Research are provided here courtesy of Elsevier

RESOURCES